Nutralife Biosciences Shares Owned By Insiders vs. Total Debt
| NLBS Stock | USD 0.0001 0.00 0.00% |
For Nutralife Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nutralife Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nutralife Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nutralife Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nutralife Biosciences over time as well as its relative position and ranking within its peers.
Nutralife |
Nutralife Biosciences Total Debt vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nutralife Biosciences's current stock value. Our valuation model uses many indicators to compare Nutralife Biosciences value to that of its competitors to determine the firm's financial worth. Nutralife Biosciences is regarded fourth in shares owned by insiders category among its peers. It is rated below average in total debt category among its peers making up about 217.64 of Total Debt per Shares Owned By Insiders. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutralife Biosciences' earnings, one of the primary drivers of an investment's value.Nutralife Total Debt vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Nutralife Biosciences |
| = | 45.95 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Nutralife Biosciences |
| = | 10 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Nutralife Total Debt vs Competition
Nutralife Biosciences is rated below average in total debt category among its peers. Total debt of Drug Manufacturers—Specialty & Generic industry is now estimated at about 5.59 Million. Nutralife Biosciences adds roughly 10,000 in total debt claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Nutralife Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nutralife Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nutralife Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Nutralife Biosciences' change in net profit over the period of time. It can combine multiple indicators of Nutralife Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
Nutralife Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nutralife Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nutralife Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nutralife Biosciences' important profitability drivers and their relationship over time.
Use Nutralife Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nutralife Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutralife Biosciences will appreciate offsetting losses from the drop in the long position's value.Nutralife Biosciences Pair Trading
Nutralife Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Nutralife Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nutralife Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nutralife Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nutralife Biosciences to buy it.
The correlation of Nutralife Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nutralife Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nutralife Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nutralife Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nutralife Biosciences position
In addition to having Nutralife Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.